SensiQuattro Candida EU is an innovative diagnostic panel designed for determining the susceptibility of Candida spp. to antifungal agents. This advanced tool is essential for the management of fungal infections, enabling healthcare professionals to obtain rapid and accurate results.

Product Features

• Format: 32-well panel


• Included Antifungals: 8 dried antifungals


• Concentrations: Four twofold serial concentrations

Advantages of SensiQuattro Candida EU

Using SensiQuattro Candida EU, laboratories can:

• Rapidly identify the susceptibility or resistance of Candida spp. to various antifungal agents.


• Use results based on interpretive criteria defined by EUCAST (The European Committee on Antimicrobial Susceptibility Testing).


• Optimize antifungal therapies, thereby improving clinical outcomes for patients.

Clinical Applications

The SensiQuattro Candida EU panel is particularly useful in various clinical situations, including:

• Treatment of fungal infections in immunocompromised patients.


• Management of recurrent Candida infections.


• Monitoring antifungal resistance in high-risk populations.

Instructions for Use

To use SensiQuattro Candida EU, it is necessary to follow the instructions provided in the kit. Preparation and interpretation of the results must be performed by qualified personnel, thereby ensuring the reliability of the information obtained.

Conclusion

In summary, SensiQuattro Candida EU represents an effective solution for the diagnosis and treatment of Candida spp. infections. Thanks to its ability to provide rapid and precise results, this panel is an indispensable ally in the fight against fungal infections.